Christopher J Lord

41PUBLICATIONS
348CO-AUTHORS
Molecular targetsHealth and ecological risk assessmentHaematological tumoursCancer geneticsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

|Jul 10, 2026
The PRECISE European initiative for cancer-vulnerability mapping and prediction.

|Jun 02, 2026
Nucleophagy removes cytotoxic trapped PARP1.

|May 06, 2026
Two decades of PARP inhibitor synthetic lethality in cancer.

|Mar 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

Callum Walker, Gabriel Kollarovic, Daniel Weekes

|Feb 23, 2026
Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposium.

Ludovica Proietti, Pedro Beltrao, Alejandra Bruna

Pageof 7

Frequent Collaborators

20 joint publications

Stephen Pettitt

14 joint publications

Andrew Tutt

13 joint publications

Syed Haider

11 joint publications

Jyoti S Choudhary